In silico approach to probe the binding affinity between OMVs harboring the Z
Affibody
Epidermal growth factor receptor (EGFR)
Molecular dynamic
RMSD
RoG
Journal
Journal of molecular modeling
ISSN: 0948-5023
Titre abrégé: J Mol Model
Pays: Germany
ID NLM: 9806569
Informations de publication
Date de publication:
05 Apr 2022
05 Apr 2022
Historique:
received:
26
09
2021
accepted:
25
01
2022
entrez:
6
4
2022
pubmed:
7
4
2022
medline:
8
4
2022
Statut:
epublish
Résumé
There is a growing interest in designing a nanocarrier containing an EGFR targeting affibody to direct toward cancer cells. Here, cytolysin A was cloned at the N-terminus of Z
Identifiants
pubmed: 35381900
doi: 10.1007/s00894-022-05043-9
pii: 10.1007/s00894-022-05043-9
doi:
Substances chimiques
Peptides
0
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113Subventions
Organisme : Pasteur Institute of Iran
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19(3):183–232. https://doi.org/10.1016/1040-8428(94)00144-I
doi: 10.1016/1040-8428(94)00144-I
pubmed: 7612182
Normanno N, Bianco C, De Luca A, Salomon DS (2001) The role of EGF related peptides in tumor growth. Front Biosci 6:D685-707. https://doi.org/10.2741/normano
doi: 10.2741/normano
pubmed: 11333208
Huang W, Wang S, Yao Y, Xia Y, Yang X, Li K et al (2016) Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection. Sci Rep 6:37242. https://doi.org/10.1038/srep37242
doi: 10.1038/srep37242
pubmed: 27849050
pmcid: 5110958
Nokleby H, Aavitsland P, O’Hallahan J, Feiring B, Tilman S, Oster P (2007) Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease. Vaccine 25(16):3080–3084. https://doi.org/10.1016/j.vaccine.2007.01.022
doi: 10.1016/j.vaccine.2007.01.022
pubmed: 17287053
Pathirana RD, Kaparakis-Liaskos M (2016) Bacterial membrane vesicles: biogenesis, immune regulation and pathogenesis. Cell Microbiol 18(11):1518–1524. https://doi.org/10.1111/cmi.12658
doi: 10.1111/cmi.12658
pubmed: 27564529
Ellis TN, Leiman SA, Kuehn MJ (2010) Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components. Infect Immun 78(9):3822–3831. https://doi.org/10.1128/IAI.00433-10
doi: 10.1128/IAI.00433-10
pubmed: 20605984
pmcid: 2937433
Vanaja SK, Russo AJ, Behl B, Banerjee I, Yankova M, Deshmukh SD, Rathinam VA (2016) Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation. Cell 165(5):1106–1119. https://doi.org/10.1016/j.cell.2016.04.015
doi: 10.1016/j.cell.2016.04.015
pubmed: 27156449
pmcid: 4874922
Olofsson A, Nygård Skalman L, Obi I et al (2014) Uptake of Helicobacter pylori vesicles is facilitated by clathrin-dependent and clathrin-independent endocytic pathways. MBio 5(3):e00979-14. https://doi.org/10.1128/mBio.00979-14
doi: 10.1128/mBio.00979-14
pubmed: 24846379
pmcid: 4030451
Furuta N, Tsuda K, Omori H, Yoshimori T, Yoshimura F, Amano A (2009) Porphyromonas gingivalis outer membrane vesicles enter human epithelial cells via an endocytic pathway and are sorted to lysosomal compartments. Infect Immun 77(10):4187–4196. https://doi.org/10.1128/IAI.00009-09
doi: 10.1128/IAI.00009-09
pubmed: 19651865
pmcid: 2747946
Parker H, Chitcholtan K, Hampton MB, Keenan JI (2010) Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells. Infect Immun 78(12):5054–5061. https://doi.org/10.1128/IAI.00299-10
doi: 10.1128/IAI.00299-10
pubmed: 20876296
pmcid: 2981328
Farasat A, Rahbarizadeh F, Hosseinzadeh G, Sajjadi S, Kamali M (2016) Affinity enhancement of nanobody binding to EGFR: in silico site-directed mutagenesis and molecular dynamics simulation approaches. J Biomol Struct Dyn 35(8):1710–1728. https://doi.org/10.1080/07391102.2016.1192065
doi: 10.1080/07391102.2016.1192065
pubmed: 27691399
Friedman M, Nordberg E, Höidén-Guthenberg I, Brismar H, Adams GP, Nilsson FY, Carlsson J, Ståhl S (2007) Phage display selection of affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor. Protein Eng Des Sel 20(4):189–199. https://doi.org/10.1093/protein/gzm011
doi: 10.1093/protein/gzm011
pubmed: 17452435
Tolmachev V, Friedman M, Sandström M, Eriksson TLJ, Rosik D, Hodik M, Ståhl S, Frejd FY, Orlova A (2009) Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry. J Nucl Med 50(2):274–283. https://doi.org/10.2967/jnumed.108.055525
doi: 10.2967/jnumed.108.055525
pubmed: 19164241
Nordberg E, Friedman M, Göstringa L, Adams GP, Brismare H, Nilssona FY, Ståhlb S, Glimeliusf B, Carlssona J (2007) Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule. Nucl Med Biol 34(6):609–618. https://doi.org/10.1016/j.nucmedbio.2007.05.010
doi: 10.1016/j.nucmedbio.2007.05.010
pubmed: 17707800
Goormaghtigh E, De Meutter J, Szoka F, Cabiaux V, Parente RA, Ruysschaert JM (1991) Secondary structure and orientation of the amphipathic peptide GALA in lipid structures. An infrared-spectroscopic approach. Eur J Biochem 195(2):421–429. https://doi.org/10.1111/j.1432-1033.1991.tb15721.x
doi: 10.1111/j.1432-1033.1991.tb15721.x
pubmed: 1997324
Sepahdar Z, Miroliaei M, Bouzari S, Khalaj V, Salimi M (2021) Surface engineering of Escherichia coli-derived OMVs as promising nano-carriers to target EGFR-overexpressing breast cancer cells. Front Pharmacol 16:719289. https://doi.org/10.3389/fphar.2021.719289
doi: 10.3389/fphar.2021.719289
Kakudo T, Chaki S, Futaki S, Nakase I, Akaji K, Kawakami T et al (2004) Transferrin-modified liposomes equipped with a pH-Sensitive fusogenic peptide: an artificial viral-like delivery system. Biochem 43(19):5618–5628. https://doi.org/10.1021/bi035802w
doi: 10.1021/bi035802w
Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5(4):725–738. https://doi.org/10.1038/nprot.2010.5
doi: 10.1038/nprot.2010.5
pubmed: 20360767
pmcid: 2849174
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291. https://doi.org/10.1107/S0021889892009944
doi: 10.1107/S0021889892009944
Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2(9):1511–1519. https://doi.org/10.1002/pro.5560020916
doi: 10.1002/pro.5560020916
pubmed: 8401235
pmcid: 2142462
Kozakov D, Hall DR, Xia B et al (2017) The ClusPro web server for protein–protein docking. Nat Protoc 12(2):255–278. https://doi.org/10.1038/nprot.2016.169
doi: 10.1038/nprot.2016.169
pubmed: 28079879
pmcid: 5540229
DeLano WL (2002) The PyMOL molecular graphics system on world wide web. http://www.pymol.org
Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51(10):2778–2786. https://doi.org/10.1021/ci200227u
doi: 10.1021/ci200227u
pubmed: 21919503
Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, Shaw DE (2010) Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78(8):1950–1958. https://doi.org/10.1002/prot.22711
doi: 10.1002/prot.22711
pubmed: 20408171
pmcid: 2970904
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Inf Model 79:926. https://doi.org/10.1063/1.445869
doi: 10.1063/1.445869
Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. https://doi.org/10.1016/j.softx.2015.06.001
doi: 10.1016/j.softx.2015.06.001
Fuglebakk E, Echave J, Reuter N (2012) Measuring and comparing structural fluctuation patterns in large protein datasets. Bioinform 28(19):2431–2440. https://doi.org/10.1093/bioinformatics/bts445
doi: 10.1093/bioinformatics/bts445
Nimrod G, Fischman S, Austin M, Herman A, Keyes F, Leiderman O, Hargreaves D et al (2018) Computational design of epitope-specific functional antibodies. Cell Repor 25(8):2121–2131. https://doi.org/10.1016/j.celrep.2018.10.081
doi: 10.1016/j.celrep.2018.10.081
Huang PS, Love JJ, Mayo SL (2007) A de novo designed protein- protein interface. Protein Sci 16(12):2770–2774. https://doi.org/10.1110/ps.073125207
doi: 10.1110/ps.073125207
pubmed: 18029425
pmcid: 2222823
Zhu C, Zhang C, Zhang T, Zhang X, Shen Q, Tang B, Liang H, Lai L (2016) Rational design of TNFα binding proteins based on the de novo designed protein DS119. Protein Sci 25(11):2066–2075. https://doi.org/10.1002/pro.3029
doi: 10.1002/pro.3029
pubmed: 27571536
pmcid: 5079244
Peled S, Leiderman O, Charar R, Efroni G, Shav-Tal Y, Ofran Y (2016) De-novo protein function prediction using DNA binding and RNA binding proteins as a test case. Nat Commun 7:13424. https://doi.org/10.1038/ncomms13424
doi: 10.1038/ncomms13424
pubmed: 27869118
pmcid: 5121330
Sela-Culang I, Benhnia MR, Matho MH, Kaever T, Maybeno M, Schlossman A, Nimrod G, Li S, Xiang Y, Zajonc D, Crotty S, Ofran Y, Peters B (2014) Using a combined computational-experimental approach to predict antibody-specific B cell epitopes. Structure 22(4):646–57. https://doi.org/10.1016/j.str.2014.02.003
doi: 10.1016/j.str.2014.02.003
pubmed: 24631463
Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK (2012) Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets 16(1):15–3. https://doi.org/10.1517/14728222.2011.648617
doi: 10.1517/14728222.2011.648617
pubmed: 22239438
pmcid: 3291787
Bitto NJ, Kaparakis-Liaskos M (2017) The therapeutic benefit of bacterial membrane vesicles. Int J Mol Sci 18(6):1287. https://doi.org/10.3390/ijms18061287
doi: 10.3390/ijms18061287
pmcid: 5486109
Rathnayake S, Weerasinghe S (2018) Exploring the binding properties of agonists interacting with glucocorticoid receptor: an in silico approach. J Mol Model 24(12):342. https://doi.org/10.1007/s00894-018-3879-1
doi: 10.1007/s00894-018-3879-1
pubmed: 30460461